Journal News

JLR: A close-up of nascent HDL formation

Laurel Oldach
Jan. 1, 2019

Oil and water don’t mix. But our aqueous blood is full of hydrophobic lipids — including cholesterol. To travel via the bloodstream, those lipids must hitch a ride on an amphipathic carrier. In a paper in the Journal of Lipid Research, scientists at Boston University report an advance in our mechanistic understanding of how one such carrier forms.

“Lipoproteins are like boats that deliver and remove cargoes of fatty substances to and from our cells,” said David Atkinson, chair of the physiology and biophysics department at Boston University School of Medicine and senior author on the JLR paper.

The subset of those “boats” that carry cholesterol and other lipids to the liver from other parts of the body are called high-density lipoproteins, or HDL, aka “good cholesterol.” HDL can remove cholesterol from distal cells — such as macrophages in the walls of arteries, where cholesterol accumulation can lead to heart attacks — and deliver it to liver cells, a process known as reverse cholesterol transport. The liver disposes of excess cholesterol by converting it into bile acids secreted into the small intestine.

According to Atkinson, a biophysicist, most of what is known about HDL formation comes from experiments that take a cell biological tack. In such studies, he said, “You can see (HDL formation) happening, and you can quantitate what happens, but you don’t understand the driving interactions that cause it to happen.”

HDL is built on a scaffold protein, apolipoprotein A-I. This apoA-I is thought to collect cholesterol and phospholipids from the cell membrane. Atkinson’s team wanted to better understand that process.

Lipoprotein particleA model of a high-density lipoprotein particle shows apolipoprotein A-I in pink, phospholipids in gray and cholesterol in yellow.Wu et al/JBC 2009ApoA-I depends on a lipid transporter protein, ABCA1, that pumps cholesterol from the inner to the outer leaflet of the cell membrane. Because the cholesterol that ABCA1 transfers usually ends up bound to apoA-I, some researchers suspected a physical interaction between apoA-I and ABCA1. Others argued that cholesterol and phospholipids could diffuse passively and bind to apoA-I.

“Even if you demonstrate that apoA-I binds to the cell surface, you don’t actually know that it’s bound to ABCA1. It’s just bound to the cell surface,” Atkinson said. So he asked his team to see if they could “demonstrate that interaction actually happening in the isolated components.”

The team, led by graduate student Minjing Liu and supported by Xiaohu Mei and Haya Herscovitz, used isolated apoA-I and ABCA1 to test for a physical interaction. They were able to show immunoprecipitation of apoA-I with purified ABCA1.

The lab earlier had designed a mutant apoA-I with a little extra wiggle in an already flexible hinge region. For this study, they used the mutant to show that higher flexibility increased apoA-I lipidation, or the formation of nascent HDL. The team has not yet tested whether the extra-flexible mutant binds to ABCA1 better or whether binding of either form of apoA-I activates ABCA1.

But about one thing Atkinson is certain: “It’s the apoA-I/ABCA1 interaction which then enables the nascent HDL particle formation to happen as the membrane components are being transported out by ABCA1.”

Increasing reverse cholesterol transport may be a way to reduce atherosclerosis and heart disease. Atkinson is optimistic about the promise of understanding the physiological processes better.

“Translational research might be in vogue,” he said, “but remember that if you don’t do foundational basic discovery research, you will not have anything to translate.”

Laurel Oldach

Laurel Oldach is a science writer for the ASBMB.

Join the ASBMB Today mailing list

Sign up to get updates on articles, interviews and events.

Latest in Science

Science highlights or most popular articles

Part 1: ‘Aha moments’ essay contest honorable mentions
Contest

Part 1: ‘Aha moments’ essay contest honorable mentions

May 6, 2021

To celebrate our three journals going open access, we invited readers to share their moments of discovery in science. Here are two honorable mentions.

From the journals: MCP
Journal News

From the journals: MCP

May 6, 2021

Using silver nanoparticles to target cancer. Glycosylation of SARS-CoV-2. Characterizing the glycan signature in tumor tissue. Read about recent papers in the journal Molecular & Cellular Proteomics.

Ceramides’ role in liver disease
Lipid News

Ceramides’ role in liver disease

May 5, 2021

These biologically active sphingolipids have roles in apoptosis, inflammation and insulin resistance, all critical factors in the pathogenesis of chronic liver disease.

Winners of the ‘aha moments’ essay contest
Contest

Winners of the ‘aha moments’ essay contest

May 4, 2021

To celebrate our three journals going open access, we invited readers to share their moments of discovery in science. Here are the first, second and third place winners.

The 17th-century cloth merchant who discovered the vast realm of tiny microbes
News

The 17th-century cloth merchant who discovered the vast realm of tiny microbes

May 2, 2021

Although untrained in science, Antonie van Leeuwenhoek became the greatest lens-maker of his day, discovered microscopic life forms and is known today as the “father of microbiology.”

Do kids really need to be vaccinated for COVID?
News

Do kids really need to be vaccinated for COVID?

May 1, 2021

Many experts argue that Covid-19 cannot be curbed without vaccinating children. But others aren’t so sure.